http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011322813-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51f95273815aea14e23dffd10ffc2208 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate | 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4323af24905d1fcdbcdee9f0f626541c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97904cb983aa7a1b1e68888259849f9 |
| publicationDate | 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011322813-A1 |
| titleOfInvention | Medicinal product comprising hydromorphone, with improved shelf-life |
| abstract | The invention relates to an active ingredient-containing particle with delayed release of active ingredient, comprising a core which contains the active ingredient, and a delayed-release coating that delays the release of the active ingredient, this active ingredient comprising hydromorphone or a salt or solvate thereof, where the core comprises the hydromorphone or the pharmaceutically tolerated salt or the solvate thereof in a mixture with an antioxidant. |
| priorityDate | 2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.